Your browser doesn't support javascript.
loading
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice.
Jamme, Philippe; Descarpentries, Clotilde; Gervais, Radj; Dansin, Eric; Wislez, Marie; Grégoire, Valérie; Richard, Nicolas; Baldacci, Simon; Rabbe, Nathalie; Kyheng, Maeva; Kherrouche, Zoulika; Escande, Fabienne; Copin, Marie Christine; Cortot, Alexis B.
Afiliação
  • Jamme P; Thoracic Oncology Department, Univ. Lille CHU Lille, Lille, France; UMR 8161 M3T Mechanisms of Tumorigenesis and Targeted Therapies, Univ. Lille CNRS Institut Pasteur de Lille, Lille, France.
  • Descarpentries C; Oncology and Molecular Genetics-Laboratory Division of Biochemistry and Molecular Biology, CHU Lille Univ. Lille, Lille, France.
  • Gervais R; Thoracic Oncology Department, Centre François Baclesse, Caen, France.
  • Dansin E; Head and Neck and Thoracic Cancers Department, Centre Oscar Lambret, Lille, France.
  • Wislez M; Service de Pneumologie, AP-HP Hôpital Tenon Sorbonne Universités- UPMC Univ Paris 06 -GRC n°04 Theranoscan, Paris, France.
  • Grégoire V; Institut de Pathologie, Univ. Lille CHU Lille, Lille, France.
  • Richard N; Department of Genetics-Molecular Genetics Laboratory UNICAEN EA7450 BioTARGen, Caen Normandy University CHU de Caen, Caen, France.
  • Baldacci S; Thoracic Oncology Department, Univ. Lille CHU Lille, Lille, France.
  • Rabbe N; Service de Pneumologie, AP-HP Hôpital Tenon Sorbonne Universités- UPMC Univ Paris 06 -GRC n°04 Theranoscan, Paris, France.
  • Kyheng M; EA 2694 Santé publique: épidémiologie et qualité des soins, Univ. Lille CHU Lille, Lille, France.
  • Kherrouche Z; UMR 8161 M3T Mechanisms of Tumorigenesis and Targeted Therapies, Univ. Lille CNRS Institut Pasteur de Lille, Lille, France.
  • Escande F; Oncology and Molecular Genetics-Laboratory Division of Biochemistry and Molecular Biology, CHU Lille Univ. Lille, Lille, France.
  • Copin MC; UMR 8161 M3T Mechanisms of Tumorigenesis and Targeted Therapies, Univ. Lille CNRS Institut Pasteur de Lille, Lille, France; Institut de Pathologie, Univ. Lille CHU Lille, Lille, France.
  • Cortot AB; Thoracic Oncology Department, Univ. Lille CHU Lille, Lille, France; UMR 8161 M3T Mechanisms of Tumorigenesis and Targeted Therapies, Univ. Lille CNRS Institut Pasteur de Lille, Lille, France. Electronic address: alexis.cortot@chru-lille.fr.
Clin Lung Cancer ; 20(4): 297-304.e1, 2019 07.
Article em En | MEDLINE | ID: mdl-31147208
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Crizotinibe / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Crizotinibe / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article